Relay Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 02/14/2025 | 27.90 M | $114.97 M | 0.00% | 19.90% |
| VANGUARD GROUP INC | 02/11/2025 | 15.03 M | $61.92 M | 3.92% | 10.72% |
| BLACKROCK, INC. | 02/07/2025 | 14.67 M | $60.46 M | 24.97% | 10.46% |
| CASDIN CAPITAL, LLC | 02/14/2025 | 8.95 M | $36.87 M | -3.27% | 6.38% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 8.07 M | $33.24 M | 126.12% | 5.75% |
| BELLEVUE GROUP AG | 02/14/2025 | 7.38 M | $30.39 M | 0.00% | 5.26% |
| NORGES BANK | 02/12/2025 | 5.78 M | $23.82 M | 100.00% | 4.12% |
| STATE STREET CORP | 02/14/2025 | 5.28 M | $21.75 M | 22.78% | 3.77% |
| JPMORGAN CHASE & CO | 02/12/2025 | 4.98 M | $20.51 M | -9.77% | 3.55% |
| NEXTECH INVEST LTD. | 02/14/2025 | 3.85 M | $15.85 M | 0.00% | 2.74% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 3.32 M | $13.69 M | -37.09% | 2.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.03 M | $12.49 M | 10.90% | 2.16% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 2.96 M | $12.22 M | 69.56% | 2.11% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 2.71 M | $11.15 M | 36.98% | 1.93% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 2.68 M | $11.05 M | 0.00% | 1.91% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 2.57 M | $10.58 M | 142.39% | 1.83% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 2.27 M | $9.35 M | 11.60% | 1.62% |
| FINEPOINT CAPITAL LP | 02/13/2025 | 2.18 M | $8.96 M | 33.79% | 1.55% |
| CANDRIAM S.C.A. | 02/07/2025 | 1.73 M | $7.12 M | 58.25% | 1.23% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 1.59 M | $6.56 M | 18.03% | 1.14% |
| ALPHABET INC. | 02/07/2025 | 1.57 M | $6.46 M | 0.00% | 1.12% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.55 M | $6.38 M | 130.85% | 1.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.40 M | $5.77 M | -15.15% | 1.00% |
| MORGAN STANLEY | 02/14/2025 | 1.30 M | $5.36 M | 35.20% | 0.93% |
| NORTHERN TRUST CORP | 02/14/2025 | 1.17 M | $4.82 M | 24.70% | 0.83% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 1.16 M | $4.78 M | 0.00% | 0.83% |
| EXOME ASSET MANAGEMENT LLC | 02/14/2025 | 1.08 M | $4.46 M | 161.31% | 0.77% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.01 M | $4.16 M | -2.41% | 0.72% |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 02/14/2025 | 1.00 M | $4.12 M | 0.00% | 0.71% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/14/2025 | 1.00 M | $4.12 M | 100.00% | 0.71% |
| ALGERT GLOBAL LLC | 02/14/2025 | 994.92 K | $4.10 M | 93.84% | 0.71% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 978.14 K | $4.03 M | 137.49% | 0.70% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 927.14 K | $3.82 M | -49.06% | 0.66% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 816.09 K | $3.36 M | -19.64% | 0.58% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 693.31 K | $2.86 M | -0.01% | 0.49% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 692.28 K | $2.85 M | 100.00% | 0.49% |
| CITADEL ADVISORS LLC | 02/14/2025 | 686.88 K | $2.83 M | -76.39% | 0.49% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 653.43 K | $2.69 M | 137.52% | 0.47% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 641.43 K | $2.64 M | -74.34% | 0.46% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 638.90 K | $2.63 M | 4.02% | 0.46% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 623.34 K | $2.57 M | -49.34% | 0.44% |
| BESSEMER GROUP INC | 02/13/2025 | 584.46 K | $2.41 M | -0.03% | 0.42% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 549.65 K | $2.26 M | 45.93% | 0.39% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 541.12 K | $2.23 M | 0.00% | 0.39% |
| 02/14/2025 | 536.13 K | $2.21 M | 100.00% | 0.38% | |
| 02/14/2025 | 505.78 K | $2.08 M | 100.00% | 0.36% | |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 500.55 K | $2.06 M | 100.00% | 0.36% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2025 | 460.00 K | $1.90 M | 0.00% | 0.33% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 457.29 K | $1.88 M | -63.46% | 0.33% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 354.50 K | $1.46 M | 100.00% | 0.25% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Relay Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 202 institutional investors and hedge funds held shares of Relay Therapeutics, Inc.. The most heavily invested institutionals were:
Ronald Blue Trust, Inc.: 0
SB INVESTMENT ADVISERS (UK) LTD: 27.9 M
VANGUARD GROUP INC: 15.03 M
Casdin Capital, LLC: 8.95 M
TANG CAPITAL MANAGEMENT LLC: 8.07 M
Bellevue Group AG: 7.38 M
116.93% of Relay Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 157.20 M shares in the last 24 months. This purchase volume represents approximately $523.49 M in transactions.